Eugene C. Petrella

2.6k total citations · 1 hit paper
17 papers, 1.6k citations indexed

About

Eugene C. Petrella is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eugene C. Petrella has authored 17 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eugene C. Petrella's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Complement system in diseases (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Eugene C. Petrella is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Complement system in diseases (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Eugene C. Petrella collaborates with scholars based in United States, Switzerland and Germany. Eugene C. Petrella's co-authors include James C. Myslik, Pamela Lane, Michael W. Pantoliano, E. R. Graf, Victor S. Lobanov, Barry A. Springer, F.R. Salemme, Carl‐Wilhelm Vogel, Michael Brigham‐Burke and Anne L. Plant and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemistry.

In The Last Decade

Eugene C. Petrella

17 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery

2001 704 citations Michael W. Pantoliano, Eugene C. Petrella et al. SLAS DISCOVERY profile →

Peers

Eugene C. Petrella

IMMUN

ONCOL

RNMI

Ann Aulabaugh United States

P. Dokurno United Kingdom

Claude Nicolau United States

Herbert Treutlein Australia

Paul E. Morin United States

P.J. Finerty Canada

Claus Spitzfaden United Kingdom

Seth F. Harris United States

Marcel Joniau Belgium

Hans Ippel Netherlands

Ann Aulabaugh United States

Eugene C. Petrella

1.3k ×1.2

211 ×0.9

IMMUN

93 ×0.5

167 ×1.0

ONCOL

131 ×0.8

RNMI

Citations per year, relative to Eugene C. Petrella Eugene C. Petrella (= 1×) peers Ann Aulabaugh

Countries citing papers authored by Eugene C. Petrella

Since Specialization

Citations

This map shows the geographic impact of Eugene C. Petrella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene C. Petrella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene C. Petrella more than expected).

Fields of papers citing papers by Eugene C. Petrella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene C. Petrella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene C. Petrella. The network helps show where Eugene C. Petrella may publish in the future.

Co-authorship network of co-authors of Eugene C. Petrella

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene C. Petrella. A scholar is included among the top collaborators of Eugene C. Petrella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene C. Petrella. Eugene C. Petrella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Burgett, Anthony W. G., Thomas B. Poulsen, Kittikhun Wangkanont, et al.. (2011). Natural products reveal cancer cell dependence on oxysterol-binding proteins. Nature Chemical Biology. 7(9). 639–647. 208 indexed citations

Schirle, Markus, Eugene C. Petrella, Scott M. Brittain, et al.. (2011). Kinase Inhibitor Profiling Using Chemoproteomics. Methods in molecular biology. 795. 161–177. 12 indexed citations

Parks, Daniel J., Louis V. LaFrance, Raul R. Calvo, et al.. (2004). 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR. Bioorganic & Medicinal Chemistry Letters. 15(3). 765–770. 130 indexed citations

Jin, Lei, Scott Pluskey, Eugene C. Petrella, et al.. (2004). The Three-dimensional Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine. Journal of Biological Chemistry. 279(41). 42818–42825. 51 indexed citations

Pantoliano, Michael W., Eugene C. Petrella, Victor S. Lobanov, et al.. (2001). High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery. SLAS DISCOVERY. 6(6). 429–440. 704 indexed citations breakdown →

Pantoliano, Michael W., Eugene C. Petrella, Victor S. Lobanov, et al.. (2001). High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery. 6(6). 429–440. 22 indexed citations

Juhl, Hartmut, Eugene C. Petrella, Nai‐Kong V. Cheung, Reinhard Bredehorst, & Carl‐Wilhelm Vogel. (1997). Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells. Immunobiology. 197(5). 444–459. 21 indexed citations

Petrella, Eugene C., Laura M. Machesky, Jozef Kaiser, & Thomas D. Pollard. (1996). Structural Requirements and Thermodynamics of the Interaction of Proline Peptides with Profilin. Biochemistry. 35(51). 16535–16543. 88 indexed citations

Plant, Anne L., Michael Brigham‐Burke, Eugene C. Petrella, & Daniel J. O’Shannessy. (1995). Phospholipid/Alkanethiol Bilayers for Cell-Surface Receptor Studies by Surface Plasmon Resonance. Analytical Biochemistry. 226(2). 342–348. 159 indexed citations

10.

Ollert, Markus, Jan Kadlec, Kerstin A. David, et al.. (1994). Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.. The Journal of Immunology. 153(5). 2213–2221. 41 indexed citations

11.

Gowda, D. Channe, et al.. (1994). Immunoreactivity and function of oligosaccharides in cobra venom factor.. The Journal of Immunology. 152(6). 2977–2986. 34 indexed citations

12.

Gowda, D. Channe, Eugene C. Petrella, Reinhard Bredehorst, & Carl‐Wilhelm Vogel. (1993). Correction to Abstract 8.09 from the Twenty-First Annual Meeting of the Society for Complex Carbohydrates. Glycobiology. 3(3). 192–192. 1 indexed citations

13.

Ollert, Markus, et al.. (1993). Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.. PubMed. 53(3). 592–9. 5 indexed citations

14.

Fritzinger, David C., et al.. (1992). Primary structure of cobra complement component C3. The Journal of Immunology. 149(11). 3554–3562. 50 indexed citations

15.

Juhl, Hartmut, Eugene C. Petrella, Nai‐Kong V. Cheung, Reinhard Bredehorst, & Carl‐Wilhelm Vogel. (1990). Complement killing of human neuroblastoma cells: A cytotoxic monoclonal antibody and its F(ab)'2-cobra venom factor conjugate are equally cytotoxic. Molecular Immunology. 27(10). 957–964. 33 indexed citations

16.

Ollert, Markus, Raymond Frade, Eugene C. Petrella, et al.. (1990). C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells.. The Journal of Immunology. 144(10). 3862–3867. 36 indexed citations

17.

Petrella, Eugene C., Scott Wilkie, Craig A. Smith, Alton C. Morgan, & Carl‐Wilhelm Vogel. (1987). Antibody conjugates with cobra venom factor. Journal of Immunological Methods. 104(1-2). 159–172. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact